Meera R. Chappidi

Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy

Meera R. Chappidi, Max Kates, Hiten D. Patel et al. · Urologic Oncology Seminars and Original Investigations · 2016 · 128 citations · Full text

Medicine, Oncology, Urology +16

Prediction of pathological stage based on clinical stage, serum prostate‐specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era

Jeffrey J. Tosoian, Meera R. Chappidi, Zhaoyong Feng et al. · British Journal of Urology · 2016 · 126 citations · Full text

Medicine, Surgery, Urology +17

Prostate Health Index density improves detection of clinically significant prostate cancer

Jeffrey J. Tosoian, Sasha C. Druskin, Darian Andreas et al. · British Journal of Urology · 2017 · 99 citations

Medicine, Oncology, Urology +17

Cost-Benefit Analysis of a Support Program for Nursing Staff

Dane Moran, Albert W. Wu, Cheryl Connors et al. · Journal of Patient Safety · 2017 · 93 citations

Pharmacy, Health Services Administration, Budget Impact Analysis +16

Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer

Niv Milbar, Max Kates, Meera R. Chappidi et al. · Bladder Cancer · 2017 · 86 citations · Full text

Medicine, Oncology, Urology +13